This cohort study describe rates of and factors associated with discontinuation and subsequent reinitiation of glucagon-like peptide-1 receptor agonists among more than 125 000 adults with overweight or obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.